Lgd-6972, A Potent, Orally-Bioavailable, Small Molecule Glucagon Receptor Antagonist For The Treatment Of Type 2 DiabetesEric G. Vajda,Scott C. Potter,James M. Fujitaki,Raja K. Reddy,Paul D. Van Poelje,Yong-Hee Lee,Ian Henderson,Lin Zhi,Keith B. MarschkeDIABETES(2012)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要